Prevalence of sleep disturbance and the association between poor disease control in people with ankylosing spondylitis within the Australian clinical setting (ASLEEP study): a real-world observational study using the OPAL dataset

Abstract

Introduction Sleep disturbance and fatigue are commonly reported in ankylosing spondylitis (AS) but specific prevalence and the relationship to disease control are unknown. Method This retrospective non-interventional observational study of data from the OPAL dataset included patients with AS (ICD code M45, M45.0 or M08.1), aged 18 to 95 years and had completed ≥ 1 sleep questionnaire between 1 January 2019 and 30 September 2020. The prevalence of insomnia and obstructive sleep apnoea were assessed using the Insomnia Severity Index (ISI) and Multivariate Apnoea Prediction Index (MAPI), respectively. Propensity score (PS) matching based on sex, age and symptom duration increased comparability between patients administered tumour necrosis factor inhibitors (TNFi) and interleukin 17A inhibitors (IL-17Ai). Results Four hundred ninety-five patients were included. The mean ISI total score in the overall population was 8.6 ± 6.2. Self-reported moderate or severe clinical insomnia was present in 16% and 3.2% of patients, respectively. The mean MAPI score was 0.4 ± 0.3, self-reported apnoea was identified in 31.5% of patients and the mean FACIT-Fatigue score was 36.1 ± 10.7. In the PS matched population, the only treatment-related difference was the mean MAPI score (IL-17Ai 0.4 ± 0.3 and TNFi 0.3 ± 0.2, p = 0.046). Those with poor disease control (BASDAI ≥ 4) were more likely (odds ratio [OR] 7.29, 95% CI 2.37 to 22.46, p = 0.001) to have a greater severity of insomnia symptoms than those with good disease control. Conclusion In this real-world AS cohort, poor disease control was associated with sleep disturbance. Little difference in sleep disturbance was observed between biologic TNFi and IL-17Ai treatment. Key Points • Sleep disturbance and fatigue are common in patients with ankylosing spondylitis.• In our real-world cohort, self-reported apnoea was reported in one-third of patients; and one in five patients reported moderate to severe insomnia.• Those with poor disease control were more likely to experience greater sleep disturbance than those with good disease control.

The Effect of Neuropathic Pain on Sleep Quality in Patients with Axial Spondyloarthritis

“…Previous studies found poor sleep quality and high disease activity to be positively correlated. (8,26,32). In contrast to these findings we found that poor sleep was not associated with disease activity.…”

My Health Record (and E‐scripts): essential new resource for physicians—a personal perspective

“…I was especially wary of the potential for obsessive patient-initiated uploads of mounds of nonrelevant details, as well as concerns about patients interrogating my reports. However, I was also aware of the potential benefits, especially pharmacy dispensing information and hospital discharge summaries, and so I started to use MHR just over 2 years ago when it became seamlessly integrated into my clinical software system, Audit4 (Software 4 Specialists), [4][5][6] allowing effortless and 'passwordless' access to patient MHR files. With everyday use of MHR, I now appreciate that my initial concerns were unfounded, and my scepticism has been transformed into a wholehearted embracement of the system.…”

Causal Associations Between Ankylosing Spondylitis and 36 Common Mental Disorders: A Two-Sample Mendelian Randomization Study

“…Omar, Mahmud et al (2022) showed that patients with AS have a higher risk of depression and anxiety; however, these patients had a lower risk of schizophrenia (SCZ) 8 . Simultaneously, compared with the normal population, one-fth of AS patients suffer from moderate to severe insomnia and other mental disorders 9 . Another national birth cohort study con rmed that paternal AS was associated with an increased risk of autism (ASD) in offspring 10 .…”